Cases of West Nile virus infection are on the rise in Italy, with nine deaths linked to the mosquito-borne disease so far.

Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel ...

ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the 13 Best Low Risk High Growth Stocks to Buy. The company witnesses ...

Neoantigen vaccine is a promising breakthrough in tumor immunotherapy. However, the application of this highly personalized strategy in the treatment of solid tumors is hindered by several obstacles, ...

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles (herpes zoster). This ...

According to a new comprehensive report from The Insight Partners, the global patient-derived xenograft model market is observing significant growth owing ...

Prefilled syringe presentation offers a convenient administration option to healthcare professionals·         An estimated one million people develop shingles in the US each year[1]GSK plc ...

The novel oral polio vaccine type 2 elicits intestinal immune responses similar to those induced by the traditional Sabin monovalent oral polio vaccine type 2, with the strongest responses in infants.

Chronic intestinal disorders can cause malnutrition which, together with immunosuppressive treatment, further increase susceptibility to infection in already immunodeficient patients.

Immunodeficient individuals, such as older adults or people on chemotherapy, are more vulnerable to demodicosis and may have an inflammatory response to the mites and the bacteria that can colonize ...